Cita APA

Moreno-Delgado, D., Puigdellívol, M., Moreno Guillén, E., Rodríguez-Ruiz, M., Botta, J., Gasperini, P., . . . McCormick, P. J. (2020). Modulation of Dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.

Citación estilo Chicago

Moreno-Delgado, David, et al. Modulation of Dopamine D1 Receptors Via Histamine H3 Receptors Is a Novel Therapeutic Target for Huntington's Disease. 2020.

Cita MLA

Moreno-Delgado, David, et al. Modulation of Dopamine D1 Receptors Via Histamine H3 Receptors Is a Novel Therapeutic Target for Huntington's Disease. 2020.